Ashleigh Palmer is CEO & Director at Provention Bio, Inc. (PRVB). They have made 15 open-market trades across 2 companies since 2010, most recently 2023-04-27.
CIK 0001493714
13 open-market purchases totalling $457K since 2010, against 2 sales. Across 9 scored buys the stock is down 4.4% at ninety days, and 5.8 points behind the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 44% | 67% | 44% |
| Avg Move | -1.4% | +0.5% | -4.4% |
| Alpha | -3.3% | -2.3% | -5.8% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRVB | SELL | 2023-02-10 | 2023-02-14 | $10.07 | $1.0M | -16.3% | +143.4% | N/A |
| PRVB | SELL | 2023-01-18 | 2023-01-20 | $10.27 | $496K | -4.7% | -0.1% | +169.0% |
| PRVB | BUY | 2021-11-30 | 2021-12-01 | $6.66 | $25K | -12.4% | -20.1% | -11.0% |
| PRVB | BUY | 2020-08-18 | 2020-08-18 | $12.69 | $6K | -4.2% | +11.8% | +12.8% |
| PRVB | BUY | 2020-08-17 | 2020-08-17 | $12.83 | $36K | -3.9% | +7.6% | +13.4% |
| PRVB | BUY | 2019-12-20 | 2019-12-23 | $11.39 | $24K | +19.2% | +38.7% | -45.0% |
| PRVB | BUY | 2019-09-24 | 2019-09-24 | $8.38 | $25K | -15.4% | -22.6% | +44.4% |
| PRVB | BUY | 2019-08-08 | 2019-08-09 | $9.15 | $97K | +10.0% | +6.5% | -15.8% |
| PRVB | BUY | 2019-06-18 | 2019-06-18 | $10.83 | $43K | +10.0% | +4.6% | -14.0% |
| PRVB | BUY | 2018-12-28 | 2018-12-31 | $1.71 | $10K | +33.9% | +29.2% | +31.6% |
| PRVB | BUY | 2018-07-19 | 2018-07-19 | $4.00 | $150K | -50.0% | -51.4% | -56.1% |
| UGNE | BUY | 2011-12-21 | 2011-12-22 | $0.53 | $5K | N/A | N/A | N/A |
| UGNE | BUY | 2010-09-20 | 2010-09-21 | $0.70 | $6K | N/A | N/A | N/A |
| UGNE | BUY | 2010-08-12 | 2010-08-12 | $0.60 | $12K | N/A | N/A | N/A |
| UGNE | BUY | 2010-06-18 | 2010-06-21 | $0.80 | $17K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.